RESONANCE HEALTH LIMITED - Announcements

0.00%

3.8¢

Market Cap $17.88M

Technology Scientific & Technical Instruments

Resonance Health Limited is an Australia-based healthcare technology and services company... Resonance Health Limited is an Australia-based healthcare technology and services company engaged in the development and commercialization of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its portfolio includes Core Lab and artificial intelligence (AI)-powered products to partner with clinicians and radiologists for diagnosis, and management of patients. Its core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. Its other SaMDs include Cardiac T2, for the assessment of iron in the heart, and HepaFat-Scan for the assessment of fat in and around the liver. It also has several AI-assisted SaMDs, including FerriSmart, HepaFat-AI, and LiverSmart. It operates as the Clinical Trial Research Organisation (CRO) and local sponsor for a major global pharma company's clinical trial in Australia of a new drug compound.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

RHT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/22	612.83KB	Share
RHT	US CPT Code Confirmation for LiverSmart	PRICE SENSITIVE	07/02/22	374.17KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/22	376.59KB	Share
RHT	Resonance Health Enters China - Pharma Contract Signed	PRICE SENSITIVE	27/01/22	2.25MB	Share
RHT	Resonance Health Contracted for Third Party Clinical Trial	PRICE SENSITIVE	25/01/22	655.94KB	Share
RHT	Change in substantial holding		18/01/22	213.53KB	Share
RHT	US FDA Clearance for LiverSmart	PRICE SENSITIVE	30/12/21	1.44MB	Share
RHT	ASO Project New Data	PRICE SENSITIVE	20/12/21	571.67KB	Share
RHT	LiverSmart Submitted to FDA for US Regulatory Clearance	PRICE SENSITIVE	03/12/21	246.91KB	Share
RHT	Jobkeeper Announcement		29/11/21	140.7KB	Share
RHT	Results of Meeting		25/11/21	151.8KB	Share
RHT	Investor Presentation - Positioning for Growth	PRICE SENSITIVE	25/11/21	2.61MB	Share
RHT	Appointment of CMO - Professor John Olynyk		24/11/21	269.88KB	Share
RHT	ASO R&D Project - Filing of Two Patent Applications	PRICE SENSITIVE	23/11/21	251.95KB	Share
RHT	Thalassaemia International Federation to Deploy FerriSmart	PRICE SENSITIVE	12/11/21	274.17KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/10/21	479.75KB	Share
RHT	Notice of Annual General Meeting/Proxy Form		25/10/21	582.92KB	Share
RHT	Sales & Marketing Update	PRICE SENSITIVE	14/10/21	284.71KB	Share
RHT	New AI Medical Device	PRICE SENSITIVE	13/10/21	260.2KB	Share
RHT	AGM Date and Director Nomination Closing Date		07/10/21	99.88KB	Share
RHT	Appendix 4G and Corporate Governance Statement		30/09/21	333.23KB	Share
RHT	Annual Report to shareholders		30/09/21	1.76MB	Share
RHT	Change in substantial holding		28/09/21	94.34KB	Share
RHT	R&D Molecular Medicine ASON Project Results of Dosing Study		21/09/21	179.43KB	Share
RHT	Preliminary Final Report	PRICE SENSITIVE	30/08/21	992.56KB	Share
RHT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	02/08/21	1.41MB	Share
RHT	Appointment of GM - Global Sales & Marketing		28/07/21	213.79KB	Share
RHT	Change of Director's Interest Notice		01/07/21	207.86KB	Share
RHT	Cancellation of Unlisted Options		01/07/21	85.3KB	Share
RHT	Controlled Placement Facility - Extension and Increase		30/06/21	81.4KB	Share
RHT	Change of Director's Interest Notice		28/06/21	208.92KB	Share
RHT	Appointment of Managing Director	PRICE SENSITIVE	28/06/21	263.78KB	Share
RHT	Secondary Trading Notice		11/06/21	443.59KB	Share
RHT	Application for quotation of securities - RHT		11/06/21	25.06KB	Share
RHT	Resignation of CEO & Management Changes	PRICE SENSITIVE	04/06/21	252.47KB	Share
RHT	Filing of Patent Application	PRICE SENSITIVE	24/05/21	550.02KB	Share
RHT	R&D Update - Molecular Medicine ASO Project	PRICE SENSITIVE	17/05/21	253.5KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/21	369.25KB	Share
RHT	Appointment of CFO & Company Secretary		08/04/21	212.17KB	Share
RHT	Change of Director's Interest Notice		09/03/21	581.11KB	Share
RHT	Secondary Trading Notice & Appendix 2A		09/03/21	386.13KB	Share
RHT	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/21	1.04MB	Share
RHT	HepaFat-AI receives CE Marking	PRICE SENSITIVE	24/02/21	252.4KB	Share
RHT	HepaFat-AI Receives TGA Approval	PRICE SENSITIVE	18/02/21	280.7KB	Share
RHT	Trading Halt	PRICE SENSITIVE	17/02/21	570.06KB	Share
RHT	Pause in Trading	PRICE SENSITIVE	17/02/21	116.7KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/21	397.37KB	Share
RHT	Secondary Trading Notice & Appendix 2A		12/01/21	626.95KB	Share
RHT	Secondary Trading Notice & Appendix 2A		31/12/20	387.43KB	Share
RHT	Secondary Trading Notice & Appendix 2A		29/12/20	3.11MB	Share
RHT	HepaFat-AI Incorporated into Blackford Analysis	PRICE SENSITIVE	24/12/20	153.07KB	Share
RHT	Secondary Trading Notice & Appendix 2A		11/12/20	385.6KB	Share
RHT	HepaFat-AI gains US FDA clearance	PRICE SENSITIVE	09/12/20	553.37KB	Share
RHT	Trading Halt	PRICE SENSITIVE	08/12/20	198.54KB	Share
RHT	Pause in Trading	PRICE SENSITIVE	08/12/20	116.61KB	Share
RHT	Secondary Trading Notice & Appendix 2A		27/11/20	385.79KB	Share
RHT	Results of Meeting		19/11/20	89.05KB	Share
RHT	Investor Presentation November 2020		19/11/20	1.63MB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	26/10/20	375.72KB	Share
RHT	Notice of Annual General Meeting/Proxy Form		16/10/20	162.23KB	Share
RHT	Secondary Trading Notice & Appendix 2A		09/10/20	627.25KB	Share
RHT	New Pulmonary Embolism AI Solution Developed	PRICE SENSITIVE	06/10/20	151.84KB	Share
RHT	Appendix 4G and Corporate Governance Statement		30/09/20	310.83KB	Share
RHT	Annual Report to shareholders		30/09/20	4.66MB	Share
RHT	Proposed issue of Securities - RHT		10/09/20	24.65KB	Share
RHT	Execution of Licence Agreement	PRICE SENSITIVE	10/09/20	441.01KB	Share
RHT	Preliminary Final Report	PRICE SENSITIVE	20/08/20	420.51KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	28/07/20	397.3KB	Share
RHT	Additional Information on Announcement Dated 25 May 2020		26/05/20	73.78KB	Share
RHT	Resonance Health Files New Provisional Patent	PRICE SENSITIVE	25/05/20	142.25KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/20	709.11KB	Share
RHT	510(k) Application Submission to U.S. FDA		06/04/20	266.35KB	Share
RHT	Market Update	PRICE SENSITIVE	31/03/20	132.87KB	Share
RHT	Secondary Trading Notice & Appendix 2A		20/03/20	204.07KB	Share
RHT	Proposed issue of Securities - RHT		19/03/20	25.14KB	Share
RHT	Controlled Placement Facility	PRICE SENSITIVE	19/03/20	71.97KB	Share
RHT	Secondary Trading Notice & Appendix 2A		06/03/20	203.27KB	Share
RHT	Half Yearly Report and Accounts	PRICE SENSITIVE	21/02/20	1.15MB	Share
RHT	Licencee & Royalty Agreement with 3DR Laboratories	PRICE SENSITIVE	04/02/20	342.92KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/20	615.03KB	Share
RHT	Appendix 3B and Secondary Trading Notice		13/01/20	931.77KB	Share
RHT	Change of Director's Interest Notice x 4		03/12/19	518.02KB	Share
RHT	Appendix 3B and Secondary Trading Notice		03/12/19	969.34KB	Share
RHT	Results of Meeting		28/11/19	2.06MB	Share
RHT	Resonance Health Partners with Siemens healthineers	PRICE SENSITIVE	28/11/19	107.3KB	Share
RHT	Investor Presentation November 2019		25/11/19	1.87MB	Share
RHT	New AI Tool for Automated Assessment of Liver Fat	PRICE SENSITIVE	21/11/19	238.73KB	Share
RHT	Resonance Health Files Provisional Patent	PRICE SENSITIVE	20/11/19	238.71KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	28/10/19	613.15KB	Share
RHT	Notice of Annual General Meeting/Proxy Form		25/10/19	225.43KB	Share
RHT	Updated Securities Trading Policy		22/10/19	95.81KB	Share
RHT	Annual Report to shareholders		22/10/19	5.74MB	Share
RHT	Appendix 4G and Corporate Governance Statement		22/10/19	157.54KB	Share
RHT	Full Year Statutory Accounts		27/09/19	1.33MB	Share
RHT	Preliminary Final Report	PRICE SENSITIVE	27/08/19	562.49KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/19	633.31KB	Share
RHT	Resonance Health contracted new clinical trials	PRICE SENSITIVE	19/07/19	256.83KB	Share
RHT	Appendix 3B and Secondary Trading Notice		16/07/19	406.95KB	Share
RHT	Secondary Trading Notice		01/05/19	245.24KB	Share
RHT	R&D Activities Update and Appendix 3B	PRICE SENSITIVE	30/04/19	974.05KB	Share

RHT Half Yearly Report and Accounts
28/02/22	PRICE SENSITIVE	612.83KB	Share
RHT US CPT Code Confirmation for LiverSmart
07/02/22	PRICE SENSITIVE	374.17KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
31/01/22	PRICE SENSITIVE	376.59KB	Share
RHT Resonance Health Enters China - Pharma Contract Signed
27/01/22	PRICE SENSITIVE	2.25MB	Share
RHT Resonance Health Contracted for Third Party Clinical Trial
25/01/22	PRICE SENSITIVE	655.94KB	Share
RHT Change in substantial holding
18/01/22		213.53KB	Share
RHT US FDA Clearance for LiverSmart
30/12/21	PRICE SENSITIVE	1.44MB	Share
RHT ASO Project New Data
20/12/21	PRICE SENSITIVE	571.67KB	Share
RHT LiverSmart Submitted to FDA for US Regulatory Clearance
03/12/21	PRICE SENSITIVE	246.91KB	Share
RHT Jobkeeper Announcement
29/11/21		140.7KB	Share
RHT Results of Meeting
25/11/21		151.8KB	Share
RHT Investor Presentation - Positioning for Growth
25/11/21	PRICE SENSITIVE	2.61MB	Share
RHT Appointment of CMO - Professor John Olynyk
24/11/21		269.88KB	Share
RHT ASO R&D Project - Filing of Two Patent Applications
23/11/21	PRICE SENSITIVE	251.95KB	Share
RHT Thalassaemia International Federation to Deploy FerriSmart
12/11/21	PRICE SENSITIVE	274.17KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
29/10/21	PRICE SENSITIVE	479.75KB	Share
RHT Notice of Annual General Meeting/Proxy Form
25/10/21		582.92KB	Share
RHT Sales & Marketing Update
14/10/21	PRICE SENSITIVE	284.71KB	Share
RHT New AI Medical Device
13/10/21	PRICE SENSITIVE	260.2KB	Share
RHT AGM Date and Director Nomination Closing Date
07/10/21		99.88KB	Share
RHT Appendix 4G and Corporate Governance Statement
30/09/21		333.23KB	Share
RHT Annual Report to shareholders
30/09/21		1.76MB	Share
RHT Change in substantial holding
28/09/21		94.34KB	Share
RHT R&D Molecular Medicine ASON Project Results of Dosing Study
21/09/21		179.43KB	Share
RHT Preliminary Final Report
30/08/21	PRICE SENSITIVE	992.56KB	Share
RHT Quarterly Activities/Appendix 4C Cash Flow Report
02/08/21	PRICE SENSITIVE	1.41MB	Share
RHT Appointment of GM - Global Sales & Marketing
28/07/21		213.79KB	Share
RHT Change of Director's Interest Notice
01/07/21		207.86KB	Share
RHT Cancellation of Unlisted Options
01/07/21		85.3KB	Share
RHT Controlled Placement Facility - Extension and Increase
30/06/21		81.4KB	Share
RHT Change of Director's Interest Notice
28/06/21		208.92KB	Share
RHT Appointment of Managing Director
28/06/21	PRICE SENSITIVE	263.78KB	Share
RHT Secondary Trading Notice
11/06/21		443.59KB	Share
RHT Application for quotation of securities - RHT
11/06/21		25.06KB	Share
RHT Resignation of CEO & Management Changes
04/06/21	PRICE SENSITIVE	252.47KB	Share
RHT Filing of Patent Application
24/05/21	PRICE SENSITIVE	550.02KB	Share
RHT R&D Update - Molecular Medicine ASO Project
17/05/21	PRICE SENSITIVE	253.5KB	Share
RHT Appendix 4C - quarterly
29/04/21	PRICE SENSITIVE	369.25KB	Share
RHT Appointment of CFO & Company Secretary
08/04/21		212.17KB	Share
RHT Change of Director's Interest Notice
09/03/21		581.11KB	Share
RHT Secondary Trading Notice & Appendix 2A
09/03/21		386.13KB	Share
RHT Half Yearly Report and Accounts
26/02/21	PRICE SENSITIVE	1.04MB	Share
RHT HepaFat-AI receives CE Marking
24/02/21	PRICE SENSITIVE	252.4KB	Share
RHT HepaFat-AI Receives TGA Approval
18/02/21	PRICE SENSITIVE	280.7KB	Share
RHT Trading Halt
17/02/21	PRICE SENSITIVE	570.06KB	Share
RHT Pause in Trading
17/02/21	PRICE SENSITIVE	116.7KB	Share
RHT Appendix 4C - quarterly
28/01/21	PRICE SENSITIVE	397.37KB	Share
RHT Secondary Trading Notice & Appendix 2A
12/01/21		626.95KB	Share
RHT Secondary Trading Notice & Appendix 2A
31/12/20		387.43KB	Share
RHT Secondary Trading Notice & Appendix 2A
29/12/20		3.11MB	Share
RHT HepaFat-AI Incorporated into Blackford Analysis
24/12/20	PRICE SENSITIVE	153.07KB	Share
RHT Secondary Trading Notice & Appendix 2A
11/12/20		385.6KB	Share
RHT HepaFat-AI gains US FDA clearance
09/12/20	PRICE SENSITIVE	553.37KB	Share
RHT Trading Halt
08/12/20	PRICE SENSITIVE	198.54KB	Share
RHT Pause in Trading
08/12/20	PRICE SENSITIVE	116.61KB	Share
RHT Secondary Trading Notice & Appendix 2A
27/11/20		385.79KB	Share
RHT Results of Meeting
19/11/20		89.05KB	Share
RHT Investor Presentation November 2020
19/11/20		1.63MB	Share
RHT Appendix 4C - quarterly
26/10/20	PRICE SENSITIVE	375.72KB	Share
RHT Notice of Annual General Meeting/Proxy Form
16/10/20		162.23KB	Share
RHT Secondary Trading Notice & Appendix 2A
09/10/20		627.25KB	Share
RHT New Pulmonary Embolism AI Solution Developed
06/10/20	PRICE SENSITIVE	151.84KB	Share
RHT Appendix 4G and Corporate Governance Statement
30/09/20		310.83KB	Share
RHT Annual Report to shareholders
30/09/20		4.66MB	Share
RHT Proposed issue of Securities - RHT
10/09/20		24.65KB	Share
RHT Execution of Licence Agreement
10/09/20	PRICE SENSITIVE	441.01KB	Share
RHT Preliminary Final Report
20/08/20	PRICE SENSITIVE	420.51KB	Share
RHT Appendix 4C - quarterly
28/07/20	PRICE SENSITIVE	397.3KB	Share
RHT Additional Information on Announcement Dated 25 May 2020
26/05/20		73.78KB	Share
RHT Resonance Health Files New Provisional Patent
25/05/20	PRICE SENSITIVE	142.25KB	Share
RHT Appendix 4C - quarterly
28/04/20	PRICE SENSITIVE	709.11KB	Share
RHT 510(k) Application Submission to U.S. FDA
06/04/20		266.35KB	Share
RHT Market Update
31/03/20	PRICE SENSITIVE	132.87KB	Share
RHT Secondary Trading Notice & Appendix 2A
20/03/20		204.07KB	Share
RHT Proposed issue of Securities - RHT
19/03/20		25.14KB	Share
RHT Controlled Placement Facility
19/03/20	PRICE SENSITIVE	71.97KB	Share
RHT Secondary Trading Notice & Appendix 2A
06/03/20		203.27KB	Share
RHT Half Yearly Report and Accounts
21/02/20	PRICE SENSITIVE	1.15MB	Share
RHT Licencee & Royalty Agreement with 3DR Laboratories
04/02/20	PRICE SENSITIVE	342.92KB	Share
RHT Appendix 4C - quarterly
29/01/20	PRICE SENSITIVE	615.03KB	Share
RHT Appendix 3B and Secondary Trading Notice
13/01/20		931.77KB	Share
RHT Change of Director's Interest Notice x 4
03/12/19		518.02KB	Share
RHT Appendix 3B and Secondary Trading Notice
03/12/19		969.34KB	Share
RHT Results of Meeting
28/11/19		2.06MB	Share
RHT Resonance Health Partners with Siemens healthineers
28/11/19	PRICE SENSITIVE	107.3KB	Share
RHT Investor Presentation November 2019
25/11/19		1.87MB	Share
RHT New AI Tool for Automated Assessment of Liver Fat
21/11/19	PRICE SENSITIVE	238.73KB	Share
RHT Resonance Health Files Provisional Patent
20/11/19	PRICE SENSITIVE	238.71KB	Share
RHT Appendix 4C - quarterly
28/10/19	PRICE SENSITIVE	613.15KB	Share
RHT Notice of Annual General Meeting/Proxy Form
25/10/19		225.43KB	Share
RHT Updated Securities Trading Policy
22/10/19		95.81KB	Share
RHT Annual Report to shareholders
22/10/19		5.74MB	Share
RHT Appendix 4G and Corporate Governance Statement
22/10/19		157.54KB	Share
RHT Full Year Statutory Accounts
27/09/19		1.33MB	Share
RHT Preliminary Final Report
27/08/19	PRICE SENSITIVE	562.49KB	Share
RHT Appendix 4C - quarterly
29/07/19	PRICE SENSITIVE	633.31KB	Share
RHT Resonance Health contracted new clinical trials
19/07/19	PRICE SENSITIVE	256.83KB	Share
RHT Appendix 3B and Secondary Trading Notice
16/07/19		406.95KB	Share
RHT Secondary Trading Notice
01/05/19		245.24KB	Share
RHT R&D Activities Update and Appendix 3B
30/04/19	PRICE SENSITIVE	974.05KB	Share

REFRESH

First 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.8¢		Change 0.000(0.00%)		Mkt cap ! $17.88M

Open	High	Low	Value	Volume
3.8¢	3.8¢	3.8¢	$16.35K	430.3K

Buyers (Bids)

No.	Vol.	Price($)
2	52027	3.8¢

Sellers (Offers)

Price($)	Vol.	No.
3.9¢	100000	1

View Market Depth

No.	Vol.	Price($)
1	15000	0.038
2	399381	0.036
1	160000	0.035
2	164719	0.034
1	99998	0.030

Price($)	Vol.	No.
0.039	100000	1
0.041	186666	1
0.042	68181	1
0.043	1148401	1
0.044	297000	1

Last trade - 13.24pm 08/08/2025 (20 minute delay)

RHT (ASX) Chart

RESONANCE HEALTH LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available